The fact that genetic depletion of TAK1 in neurons and the prolonged treatment with 5Z-7-Oxozeaenol did not confer protection against cerebral ischemia [24] indicates that TAK1-mediated inflammation is mainly triggered in other brain cells than neurons. This evidence concerns the gene MAP3K7 and brain ischemia.